Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia

Inclusion Criteria: * Men or women between 18 and 60 years (extremes included) * BMI of ≤38 * Primary diagnosis of schizophrenia according to DSM-IV-TR™ (codes 295.10, 295.20, 295.30, 295.90) * Clinical Global Impression - Severity of Illness (CGI-S) score ≤4 (moderately ill) at screening and baseline * PANSS total score ≤80 * Score ≤4 (moderate) on the following PANSS items at screening and safety baseline: P7 (hostility), G8 (uncooperativeness) * Willing to be hospitalised for 4 to 5 weeks after the Safety Baseline Visit Exclusion Criteria: * The patient experienced an acute exacerbation requiring hospitalization within the last 6 months * The patient experienced an acute exacerbation requiring change in antipsychotic medication (with reference to drug or dose) within the last 4 weeks * The patient has a diagnosis or history of substance dependence (except nicotine) or substance abuse according to DSM-IV-TR® criteria ≤3 months prior to screening * The patient smokes \>20 cigarettes per day Other protocol-defined inclusion and exclusion criteria may apply